Figures & data
Figure 1. Forest plot of all-cause mortality among patients with chronic heart failure randomized to biomarker-guided therapy versus control. The size of the marker for the point estimate (diamond) is proportional to the sample size for each study. Horizontal lines show 95% confidence intervals. From Felker et al., American Heart Journal, 2009, with permission (Citation18).
![Figure 1. Forest plot of all-cause mortality among patients with chronic heart failure randomized to biomarker-guided therapy versus control. The size of the marker for the point estimate (diamond) is proportional to the sample size for each study. Horizontal lines show 95% confidence intervals. From Felker et al., American Heart Journal, 2009, with permission (Citation18).](/cms/asset/b2659230-a415-4657-9225-43c7d34ac966/iann_a_526630_f0001_b.gif)
Figure 2. Plasma levels of BNPsp, NT-proBNP, myoglobin, CK-MB, and troponin I in 25 patients with acute myocardial infarction and ST-segment elevation presenting within 4 hours of the onset of symptoms. Data are shown as mean ± SEM. From Siriwardena et al., Circulation, 2010, with permission (Citation71).
![Figure 2. Plasma levels of BNPsp, NT-proBNP, myoglobin, CK-MB, and troponin I in 25 patients with acute myocardial infarction and ST-segment elevation presenting within 4 hours of the onset of symptoms. Data are shown as mean ± SEM. From Siriwardena et al., Circulation, 2010, with permission (Citation71).](/cms/asset/0a671f73-d3f7-4b86-9d28-4f1f4ec9db6f/iann_a_526630_f0002_b.jpg)